Your browser doesn't support javascript.
loading
Preceding bortezomib administration for a certain period reduces the risk of lenalidomide-induced skin rash.
Sugi, Tomiyuki; Mita, Mitsuo; Yasu, Takeo; Kubo, Kana; Kushi, Ryota; Hanai, Homare; Ohara, Shin; Uchida, Tomoyuki; Inoue, Morihiro; Hagihara, Masao.
Afiliação
  • Sugi T; Department of Pharmacy, Eiju General Hospital, Taito-ku, Japan.
  • Mita M; Department of Cardiovascular Pharmacology, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Kiyose, Japan.
  • Yasu T; Department of Cardiovascular Pharmacology, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Kiyose, Japan.
  • Kubo K; Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, Kiyose, Japan.
  • Kushi R; Department of Pharmacy, Eiju General Hospital, Taito-ku, Japan.
  • Hanai H; Department of Pharmacy, Eiju General Hospital, Taito-ku, Japan.
  • Ohara S; Department of Pharmacy, Eiju General Hospital, Taito-ku, Japan.
  • Uchida T; Department of Hematology, Eiju General Hospital, Taito-ku, Japan.
  • Inoue M; Department of Hematology, Eiju General Hospital, Taito-ku, Japan.
  • Hagihara M; Department of Hematology, Eiju General Hospital, Taito-ku, Japan.
J Clin Pharm Ther ; 47(4): 477-482, 2022 Apr.
Article em En | MEDLINE | ID: mdl-34778985
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exantema / Mieloma Múltiplo Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exantema / Mieloma Múltiplo Idioma: En Ano de publicação: 2022 Tipo de documento: Article